论文部分内容阅读
目的探讨采用经动脉栓塞或经动脉栓塞联合经皮经肝穿刺瘤内注射硬化治疗不同血供特点肝海绵状血管瘤(CHL)的临床疗效。方法对2004年2月-2013年4月收治的86例不同血供特点CHL患者经股动脉插管行平阳霉素碘化油乳化剂栓塞或经动脉栓塞联合经皮经肝穿刺瘤内注射平阳霉素碘化油乳化剂硬化治疗。结果 45例(52.3%)瘤体缩小超过50%,26例(30.2%)瘤体缩小20%~50%,11例(12.8%)瘤体缩小不足20%,4例(4.7%)瘤体病灶无明显变化,所以患者无严重并发症发生。结论对于不同血供特点CHL采用个性化介入治疗效果明显,是一种安全有效的治疗方法。
Objective To investigate the clinical efficacy of transcatheter arterial embolization combined with transcatheter arterial embolization in the treatment of hepatic cavernous hemangiomas (CHL) with different blood supply. Methods From February 2004 to April 2013, 86 cases of CHL patients with different blood supply were treated with Pingyangmycin iodinated oil emulsion embolization or percutaneous transhepatic arterial embolization through femoral artery. Mycotoxin iodinated oil emulsifier sclerotherapy. Results Tumors were reduced by more than 50% in 45 cases (52.3%), 20% ~ 50% in 26 cases (30.2%), less than 20% in 11 cases (12.8% No significant change in the lesions, so patients without serious complications. Conclusion It is a safe and effective treatment for CHL with different blood supply to use personalized interventional therapy.